NRXP

NRX Pharmaceuticals Inc. Common Stock (NRXP)

Stock · NASDAQ · Health Care

$3.55as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$2.91
Industry
Biotechnology: Pharmaceutical Preparations

How NRX Pharmaceuticals Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$1.23MSG&A$13.06M (1066%)R&D$3.78M (308%)Cost of Revenue$505.0K (41%)NRXP

Source: 10-K filed Mar 23, 2026 · via SEC EDGAR / Finnhub

NRX Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • NRXP
    NRX Pharmaceuticals Inc. Common Stock
    $3.54
    ▼ 2.21%
    Market cap $117.38MP/E
  • BGM
    BGM Group Ltd. Class A Ordinary Shares
    $0.3251
    ▲ 11.34%
    Market cap $116.58MP/E
    $0.2287$11.8
  • SPRB
    Spruce Biosciences Inc. Common Stock
    $60.05
    ▼ 5.13%
    Market cap $118.73MP/E
    $7$240
  • CNTB
    Connect Biopharma Holdings Limited Ordinary Shares
    $2.22
    ▼ 2.63%
    Market cap $124.04MP/E
    $1.23$3.82
  • IFRX
    InflaRx N.V. Common Stock
    $2.22
    ▼ 2.20%
    Market cap $126.51MP/E
    $0.7984$2.95
  • PMN
    ProMIS Neurosciences Inc. Common Shares (ON)
    $13.79
    ▼ 1.43%
    Market cap $126.80MP/E
    $6.27$27.4
  • VTVT
    vTv Therapeutics Inc. Class A Common Stock
    $32.17
    ▼ 1.92%
    Market cap $127.58MP/E 55.59
    $15.79$44

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
6.26M
Total value held
$13.29M
Institutional holders
32
Top holders this quarter
  • Unknown3.00M
  • Unknown1.16M
  • Unknown420.5K
  • Unknown397.4K
  • Unknown310.1K
  • Unknown180.7K
  • Unknown117.2K
  • Unknown102.2K
  • Unknown99.0K
  • Unknown87.0K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.